(19)
(11) EP 4 798 211 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883287.5

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61K 31/5517(2006.01)
A61K 9/70(2006.01)
A61K 9/00(2006.01)
A61P 39/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0056; A61K 9/006; A61K 9/0043; A61K 31/5517; A61K 45/06
(86) International application number:
PCT/US2024/052674
(87) International publication number:
WO 2025/090681 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592568 P

(71) Applicant: Mithradote Bio, Inc.
San Diego, California 92121 (US)

(72) Inventor:
  • LEE, Sophia
    San Diego, California 92121 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) RAPIDLY DEGRADING FORMULATIONS FOR REVERSING AN ATTEMPTED INCAPACITATION